Rice Investment Group, a multi-strategy investment fund focused on a diverse array of energy-related investments, and Mercuria, one of the world's leading independent energy, metals and commodity trading firms, announce that Rice Acquisition Corporation 3 (“RAC III”), a special purpose acquisition company (“SPAC”), priced its initial public offering of 30,000,000 units at a price of […]

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstQuanex Building Products Corporation (“Quanex” or “the Company”) (NYSE: NX) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased

(NASDAQ:SMLR), Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR) To Contact Him Directly To Discuss Their Options If you purchased or acquired Semler Scientific securities between March 10, 2021 and April 15, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire

SEMLER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Semler Scientific, Inc. and Encourages Investors to Contact the Firm GlobeNewswire September 30, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR) To Contact Him Directly To Discuss Their

The Board of Directors of McCormick & Company, Incorporated (NYSE:MKC) declared a quarterly dividend of $0.45 per share on its common stocks, payable October 27, 2025, to shareholders of record October 14, 2025. This is the 101st year of consecutive dividend payments by the Company. About McCormick McCormick & Company, Incorporated is a global leader

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstCTO Realty Growth, Inc. (“CTO” or “the Company”) (NYSE: CTO) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased

(NasdaqGM:TNDM), NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business information to the investing public. SO

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire September 30, 2025 NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstAltimmune, Inc. (“Altimmune” or “the Company”) (NASDAQ: ALT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the

The DJS Law Groupannounces that it is investigating claims on behalf of investors ofLineage, Inc. (“Lineage” or “the Company”) (NASDAQ: LINE) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Lineage has suffered from multiple analyst